Top Abstract Purchase Related
Home
>
Node
>
Subnode

Migration inhibition factor and the blood clotting system: effects of defibrination, heparin and thrombin

Mäkinen, T.; Tötterman, T.H.; Gordin, A.; Weber, T.H.

Clinical and Experimental Immunology 29(1): 181-186

1977

ISSN/ISBN: 0009-9104
PMID: 330064
Document Number: 115820
Heparin is not suitable as an anticoagulant in the leucocyte migration test used to demonostrate the presence of migration inhibition factor (MIF) due to a rapid disappearance of the response after even a short storage of the blood. The use of defibrinated blood is highly recommended and defibrinated blood can be stored for at least 90 min without any diminution of the response. The change in response when using heparinized blood is not due to any direct effect of heparin, because heparin has no effect when added to defibrinated blood. However, heparin, added together with thrombin, is capable of abolishing the MIF effect completely. The basis for this phenomenon is most probably the binding of the heparin-antithrombin cofactor (AT III) to a complex with heparin and thrombin. The activity of MIF requires the presence of AT III, its esterase-inhibiting activity probably being crucial, in order to express MIF activity on macrophages. This mechanism forms a link between certain cellular immune reactions and the blood-clotting system.

Document emailed within 1 workday
Secure & encrypted payments

Béguin, S.; Lindhout, T.; Hemker, H.C. 1989: The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin Thrombosis and Haemostasis 61(1): 25-29
Kudriashov, B.A.; Baskova, I.P.; Orlova, A.S.; Shapiro, F.B. 1981: Effect of hirudin-thrombin and phenylmethylsulfonyl-thrombin on various blood clotting indices Biulleten' Eksperimental'noi Biologii i Meditsiny 91(3): 307-309
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302
Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A. 1979: Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state Folia Haematologica 106(3): 414-425
Nydahl, S.; Frebelius, S.; Swedenborg, J. 1993: Effect of heparin on thrombin inhibition in the microcirculation Thrombosis and Haemostasis 69(1): 41-44
Méndez-Samperio, P.; Jiménez-Zamudio, L.; Favila-Castillo, L. 1989: Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 41(2): 107-115
Fox, R.A.; Gregory, D.S.; Feldman, J.D. 1974: Migration inhibition factor (MIF) and migration stimulation factor (MSF) in fetal calf serum Journal of Immunology 112(5): 1861-1866
Fukutake, K.; Mimura, K.; Shinozawa, K.; Fujiwara, K.; Kobayashi, T.; Yatsuhashi, T.; Fukutake, K.; Inaba, H. 1989: Effects of ulinastatin on alpha-thrombin and the activation of protein C and factor XIIi induced by thrombin Rinsho Byori. Japanese Journal of Clinical Pathology 37(4): 416-420
Hemker, H.C.; Kop, J.; Willems, G.M. 1979: Kinetic aspects of the interaction of blood clotting enzymes. VIII. the relation between clotting time and clotting velocity Thrombosis and Haemostasis 41(2): 309-313
Efimov, V.S.; Rozkin, M.I.; Poberiĭ, I.A.; Lindner, D.P. 1981: Effect of regulating blood clotting with heparin and its antagonists on mast cells Farmakologiia i Toksikologiia 44(1): 80-85
Colucci, M.; Pentimone, A.; Binetti, B.M.; Cramarossa, M.; Piro, D.; Semeraro, N. 2002: Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin Thrombosis and Haemostasis 88(2): 282-287
Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: Inhibition of thrombin generation in plasma by inhibitors of factor Xa Thrombosis and Haemostasis 78(4): 1215-1220
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Wilhelmsson, S.; Lins, L.E. 1976: Whole-blood thrombin time: a bedside method for determination of heparin activity Clinical Nephrology 6(6): 523-525
Borkowsky, W.; Lawrence, H.S. 1979: Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay Journal of Immunology 123(4): 1741-1748
Ishmukhametova, D.N.; Mozhina, A.A. 1984: Relation of the formation of the fibrin network of a blood clot to the amount of thrombin in complexes with endogenous heparin Anesteziologiia i Reanimatologiia 2: 30-34
Weisbart, R.H.; Lusis, A.J.; Chan, G.; Billing, R.; Ashman, R.F.; Golde, D.W. 1982: Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells Journal of Immunology 128(1): 457-462
Kurbanov, K.M. 1980: The blood clotting system and the value of the clotted blood morphologic dissociation test in recognizing jaundice of different origins Vestnik Khirurgii Imeni I. I. Grekova 124(5): 135-138
Béguin, S.; Dol, F.; Hemker, H.C. 1991: Factor IX a inhibition contributes to the heparin effect Thrombosis and Haemostasis 66(3): 306-309
Kudriashov, B.A.; Liapina, L.A.; Ul'ianov, A.M. 1978: Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin Voprosy Meditsinskoi Khimii 24(2): 255-260